D64.81 Anemia due to antineoplastic chemotherapy

Billable ICD-10-CM code, FY2026.

Applicable to

• Antineoplastic chemotherapy induced anemia

Excludes2 (not included here)

• anemia in neoplastic disease (D63.0)
• aplastic anemia due to antineoplastic chemotherapy (D61.1)

Applies from D64 Other anemias

Excludes1 (never code together)

• refractory anemia (D46.-)
• refractory anemia with excess blasts in transformation [RAEB T] (C92.0-)

MS-DRG index

Defines the logic of DRG(s) 811-812 in MDC 16.

Approximate ICD-9-CM (GEMs)

• 285.3 Antineoplastic chemotherapy induced anemia

Code annotations containing back-references to D64.81

Back-references to D64.81

• Type 2 Excludes: D63.0 Anemia in neoplastic disease ("anemia due to antineoplastic chemotherapy (D64.81)")

Back-references to D64

• Code First: M90.5 Osteonecrosis in diseases classified elsewhere ("hemoglobinopathy (D50-D64)")
• Type 1 Excludes: R71 Abnormality of red blood cells ("anemias (D50-D64)")

Diagnosis Index entries for D64.81

• Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) › due to (in) (with) › antineoplastic chemotherapy
• Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) › due to (in) (with) › chemotherapy, antineoplastic

Nearby codes

• D64.1 Secondary sideroblastic anemia due to disease
• D64.2 Secondary sideroblastic anemia due to drugs and toxins
• D64.3 Other sideroblastic anemias
• D64.4 Congenital dyserythropoietic anemia
• D64.8 Other specified anemias
• D64.81 Anemia due to antineoplastic chemotherapy (this code)
• D64.89 Other specified anemias
• D64.9 Anemia, unspecified